INBX R&D to Revenue
Inhibrx Biosciences Inc · R&D to Revenue
INBX R&D to Revenue
Latest reported8694.46%period ending
INBX FY R&D/Revenue (254.87% → 8694.46%)
Latest values, visible window
High-resolution chart · PNG
INBX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 8,694.4615% | |
| 101,871.5% | |
| 10,591.5556% | |
| 5,026.7336% | |
| 1,002.6667% | |
| 573.821% | |
| 526.8558% | |
| 389.2263% | |
| 304.0162% | |
| 254.8673% |